228. Bronchiolitis obliterans Clinical trials / Disease details
Clinical trials : 97 / Drugs : 118 - (DrugBank : 32) / Drug target genes : 33 - Drug target pathways : 156
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01163786 (ClinicalTrials.gov) | October 7, 2010 | 7/7/2010 | A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD | A Phase 2 Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD | Bronchiolitis Obliterans | Drug: Bortezomib | Northwestern University | Robert H. Lurie Cancer Center | Terminated | N/A | N/A | All | 17 | Phase 2 | United States |